Stockscreener 앱 받기
90.37
11.84%
-12.01
전일 마감가:
$102.38
열려 있는:
$99.59
하루 거래량:
5.49M
Relative Volume:
2.75
시가총액:
$20.13B
수익:
$7.68B
순이익/손실:
$903.80M
주가수익비율:
20.31
EPS:
4.45
순현금흐름:
$1.14B
1주 성능:
-11.30%
1개월 성능:
-15.91%
6개월 성능:
-17.13%
1년 성능:
-25.81%
1일 변동 폭
$90.00
$99.82
1주일 범위
$90.00
$103.28
52주 변동 폭
$90.00
$122.25
짐머 바이오메트 Stock (ZBH) Company Profile
명칭
Zimmer Biomet Holdings Inc
전화
(574) 267-6131
주소
345 EAST MAIN STREET, WARSAW, IN
ZBH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
90.39 | 20.13B | 7.68B | 903.80M | 1.14B | 4.45 |
|
ABT
Abbott Laboratories
|
132.91 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.49 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.15 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.38 | 108.80B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.30 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
짐머 바이오메트 Stock (ZBH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-09-10 | 개시 | Wolfe Research | Peer Perform |
| 2024-07-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-21 | 업그레이드 | Argus | Hold → Buy |
| 2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-10-20 | 개시 | ROTH MKM | Neutral |
| 2023-08-28 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-05-03 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-04-11 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-03-31 | 업그레이드 | Jefferies | Underperform → Hold |
| 2023-03-29 | 개시 | UBS | Sell |
| 2023-03-10 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Underweight |
| 2022-10-12 | 개시 | Jefferies | Underperform |
| 2022-05-27 | 다운그레이드 | Needham | Buy → Hold |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2022-04-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-02 | 재개 | BofA Securities | Underperform |
| 2022-03-02 | 다운그레이드 | Loop Capital | Buy → Hold |
| 2022-02-08 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | 재확인 | Citigroup | Buy |
| 2022-02-08 | 재확인 | Deutsche Bank | Hold |
| 2022-02-08 | 재확인 | JMP Securities | Mkt Outperform |
| 2022-02-08 | 재확인 | JP Morgan | Neutral |
| 2022-02-08 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | 재확인 | Stifel | Buy |
| 2022-02-08 | 재확인 | Truist | Buy |
| 2022-02-08 | 재확인 | UBS | Neutral |
| 2022-02-08 | 재확인 | Wells Fargo | Underweight |
| 2022-02-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-01-19 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2021-12-07 | 개시 | Loop Capital | Buy |
| 2021-11-23 | 다운그레이드 | Argus | Buy → Hold |
| 2021-09-14 | 재개 | Raymond James | Mkt Perform |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-09 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-12-18 | 재확인 | Needham | Strong Buy |
| 2020-10-20 | 개시 | Northland Capital | Market Perform |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-08-05 | 재확인 | Needham | Strong Buy |
| 2020-04-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-04-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-04-07 | 재확인 | Needham | Strong Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2020-01-07 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2019-09-18 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | 업그레이드 | Argus | Hold → Buy |
| 2019-07-30 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2019-07-29 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | 업그레이드 | Needham | Buy → Strong Buy |
모두보기
짐머 바이오메트 주식(ZBH)의 최신 뉴스
Citi Adjusts Zimmer Biomet (ZBH) Price Target While Maintaining Neutral Stance | ZBH Stock News - GuruFocus
Zimmer Biomet (ZBH) Sees Growth from Product Launches and Acquisition - GuruFocus
Citigroup Cuts Zimmer Biomet Price Target to $104 From $118 - marketscreener.com
Piper Sandler Cuts Zimmer Biomet Price Target to $100 From $105 - marketscreener.com
ZBH Q1 Earnings Beat, Operating Margin Dips, Stock Down in Premarket - Yahoo Finance
Zimmer Biomet (ZBH) Stock Falls After EPS Guidance Cut - GuruFocus
Zimmer Biomet falls 10% after narrowing its 2025 EPS guidance range - Seeking Alpha
Zimmer biomet updates 2025 guidance with eps range of $7.90-$8.10 amid product launches - MSN
Zimmer Biomet lowers 2025 profit forecast amid tariff uncertainty, shares fall - Reuters
Zimmer Biomet Stock Plummets On 2025 Earnings Outlook Downgrade: But Retail’s Bullish - MSN
Earnings call transcript: Zimmer Biomet Q1 2025 sees stock fall despite earnings beat - Investing.com
Zimmer Biomet Scales Back 2025 Profit Forecast - Finimize
Zimmer Biomet seeks to be ‘boldest medtech company on Earth’ - MassDevice
Zimmer Biomet Revises 2025 Profit Forecast Due to Paragon 28 AcquisitionNews and Statistics - IndexBox
Zimmer Biomet lowers 2025 profit forecast on acquisition costs, tariff uncertainty - Yahoo Finance
Zimmer Biomet (ZBH) Surpasses Q1 Earnings and Revenue Estimates - Yahoo
Zimmer Biomet Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Zimmer Biomet Announces First Quarter 2025 Financial Results - BioSpace
Zimmer: Q1 Earnings Snapshot - San Francisco Chronicle
Zimmer Biomet shares rise as Q1 results top estimates By Investing.com - Investing.com UK
Zimmer Biomet (ZBH) Reports Strong Q1 Results, Eyes Innovation and Growth | ZBH Stock News - GuruFocus
Zimmer Biomet (ZBH) Beats Earnings Estimates with Robust Q1 Performance - GuruFocus
Zimmer Biomet Holdings Inc Q1 2025 Earnings: Revenue Surpasses Estimates at $1.909 Billion, EPS Falls Short at $0.91 - GuruFocus
Zimmer Biomet (NYSE:ZBH) Posts Better-Than-Expected Sales In Q1 - Yahoo Finance
Zimmer Biomet Announces First Quarter 2025 Financial Results | ZBH Stock News - GuruFocus
Zimmer Biomet earnings beat by $0.04, revenue topped estimates - Investing.com Canada
Zimmer Biomet Q1 2025 Financial Results - TradingView
(ZBH) Zimmer Biomet Holdings Expects Fiscal Year 2025 Adjusted EPS Range $7.90$8.10 - marketscreener.com
Zimmer Biomet (ZBH) Reports Q1: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2025 - GuruFocus
What Does Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Indicate? - Yahoo Finance
Insights Into Zimmer (ZBH) Q1: Wall Street Projections for Key Metrics - Nasdaq
Zimmer Biomet Holdings (NYSE:ZBH) earnings and shareholder returns have been trending downwards for the last year, but the stock rises 5.6% this past week - simplywall.st
Zimmer Biomet Holdings: Strategic Product Launches and Favorable Valuation Drive Buy Rating - TipRanks
What to Expect From Zimmer Biomet's Next Quarterly Earnings Report - MSN
Zimmer Biomet to Report Q1 Earnings: Here's What to Expect - MSN
Zimmer Biomet's SWOT analysis: medical device maker's stock faces ERP hurdles - MSN
Zimmer acquires Paragon 28 in $1.2bn deal - Yahoo Finance
What To Expect From Zimmer Biomet's Next Quarterly Earnings Report - Barchart.com
Is Zimmer Biomet Holdings, Inc. (ZBH) The Top Falling Stock with Unusual Volume? - Yahoo Finance
Zimmer Biomet Holdings (ZBH) Completes Merger with Paragon 28 - GuruFocus
Paragon 28 concludes merger with Zimmer Biomet subsidiary By Investing.com - Investing.com South Africa
Paragon 28 concludes merger with Zimmer Biomet subsidiary - Investing.com
Zimmer Biomet completes Paragon 28 acquisition - MassDevice
Zimmer Biomet Closes Paragon 28 Acquisition - marketscreener.com
Zimmer Biomet Completes Acquisition of Paragon 28 | ZBH Stock Ne - GuruFocus
Zimmer Biomet Completes Acquisition of Paragon 28 - GuruFocus
Zimmer Biomet Completes Acquisition Of Paragon 28 - marketscreener.com
Knee Replacement Market Detailed In New Research Report 2025 | - openPR.com
Maxillofacial surgery Market Projected To Witness Substantial - openPR.com
Bone Replacement Products Market Projected To Witness - openPR.com
짐머 바이오메트 (ZBH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.02%
1.79%
자본화:
|
볼륨(24시간):